Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea · Delayed Price · Currency is KRW 7,020.00
+20.00 (0.29%)
Jul 21, 2026, 2:39 PM KST
Komipharm International Market Cap
Komipharm International has a market cap or net worth of 506.39 billion as of July 20, 2026. Its market cap has increased by 27.76% in one year.
Market Cap
506.39B
Enterprise Value
524.59B
Revenue
49.99B
Ranking
n/a
PE Ratio
n/a
Stock Price
7,020.00
ChartMarket Cap Chart
Since March 1, 2002, Komipharm International's market cap has increased from 94.26B to 506.39B, an increase of 437.22%. That is a compound annual growth rate of 7.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 506.39B | -0.11% |
| Dec 30, 2025 | 506.94B | 89.57% |
| Dec 30, 2024 | 267.41B | -9.03% |
| Dec 28, 2023 | 293.94B | -34.10% |
| Dec 29, 2022 | 446.06B | -18.67% |
| Dec 30, 2021 | 548.45B | -36.13% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.62T |
| Celltrion | 40.32T |
| ALTEOGEN | 14.81T |
| Samsung Epis Holdings | 9.85T |
| JW Pharmaceutical | 553.83B |
| Dong-A Socio Holdings | 542.90B |
| WON TECH | 476.57B |
| BioNote | 475.60B |